Health News

University of Cincinnati (UC) analysis of 10 years of data from local kidney transplant patients shows that patients removed from a corticosteroid regimen shortly after surgery have better graft survival rates, better survival rates and fewer cardiovascular events than patients kept on the traditional regimen of long-term steroids.

Read more

Filed under: Pharmacy News
Tags: Pharmacy, steroid, Surgery

Related posts

• Patients with degenerative spondylolisthesis do not benefit from epidural steroid injections (0)
  Researchers at the Rothman Institute at Jefferson examined data on patients being treated for lumbar stenosis and the degenerative spine condition spondylolisthesis and found that patients who received epidural steroid injections (ESI) had a higher rate of crossover to surgery and fared worse in physical health and bodily pain versus those who did not receive [...]
  
  
• Women and minorities under-represented in trials (0)
  Enrollment demographics published in many U.S. vascular surgery randomized control trials (RCTs) under-represent women as well as race or ethnic minorities, according to a new study published in the Society for Vascular Surgery’s August 2009 issue of the Journal of Vascular Surgery. Read more [tags] Pharmacy News [/tags]
  
  
• Winners Of Glaxosmithkline International Achievement Award Announced At BPC (0)
  Professor Barry Potter, Professor of Medicinal & Biological Chemistry at the University of Bath, and the late Professor Michael Reed, Professor of Steroid Biochemistry at Imperial College, London, have won the prestigious 2009 GlaxoSmithKline (GSK) International Achievement Award. Read more [tags] Pharmacy News [/tags]
  
  
• WADA, IOC compliant safe alternatives to dangerous and illegal anabolic steroids (0)
  SteroidAlternatives.com has launched a cutting-edge line of legal, powerful, and safe alternatives to dangerous and illegal anabolic steroids. All products offered by SteroidAlternatives.com are WADA (World Anti-Doping Agency) and IOC (International Olympic Committee) compliant. This line of products is effective and offers the consumer a legal way to build superior muscle, strength, and speed without [...]
  
  
• Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports (0)
  A newly published study in The New England Journal of Medicine shows that in premenopausal women with early breast cancer administering Zometa(R) (zoledronic acid) along with post-surgery hormone therapy provided a reduction in risk of recurrence or death that was 36% beyond that achieved with hormone therapy alone(1). Read more [tags] Pharmacy News [/tags]